Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

June 02, 2015 5:55 AM ET

Healthcare Equipment and Supplies

Company Overview of ConforMIS, Inc.

Company Overview

ConforMIS, Inc., a medical technology company, develops, manufactures, and sells customized joint replacement implants. The company offers customized knee replacement products, including iTotal CR, a cruciate-retaining product; iTotal PS, a posterior cruciate ligament substituting product; iUni G2, a unicompartmental product for treatment of the medial or lateral compartment of the knee; and iDuo G2, a bicompartmental partial implant for patients with osteoarthritis of the patellofemoral compartment of the knee and either the medial or lateral compartment of the knee, as well as provides iJigs, customized single-use patient-specific instruments. It is also developing iTotal Hip, a customized...

28 Crosby Drive

Bedford, MA 01730

United States

Founded in 2004

342 Employees





Key Executives for ConforMIS, Inc.

Founder, Chief Executive Officer, President, Director and Chairman of Asia Strategy Committee
Age: 51
Chief Financial Officer
Age: 50
Senior Vice President of Operations
Age: 39
Chief Legal Officer and General Counsel
Age: 47
Senior Vice President of Knee Implant Engineering
Age: 60
Compensation as of Fiscal Year 2014.

ConforMIS, Inc. Key Developments

ConforMIS Might Seek Acquisitions

ConforMIS, Inc. has filed an IPO in the amount of $172.50 million. Although ConforMIS has no current agreements, commitments or understandings for any specific acquisitions or in-licenses at this time, it may use a portion of the net proceeds for these purposes.

ConforMIS, Inc. Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-14-2015 04:00 PM

ConforMIS, Inc. Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-14-2015 04:00 PM. Venue: Westin St. Francis Hotel, San Francisco, California, United States. Speakers: Philipp Lang, Founder, Chairman, Chief Executive Officer and President.

Bonutti Skeletal Innovations LLC Enters into Settlement and Patent License Agreement with ConforMIS, Inc

Acacia Research Corporation announced that Bonutti Skeletal Innovations LLC has entered into a settlement and patent license agreement with ConforMIS, Inc. The agreement resolves all aspects of the litigation for the United States District Court for the District of Delaware and the United States District Court for the District of Massachusetts.

Similar Private Companies By Industry

Company Name Region
FHC, Inc. United States
LL Corpus Cogere, Inc. United States
Oceanic Medical Products, Inc. United States
Home Products for Seniors, Inc. United States
The Trylon Corporation United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ConforMIS, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at